As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have ...

AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...

The data used to train the AI – including vaccination records, GP visits, hospital admissions, and A&E attendances – is being ...

The aim is to make sure that foreign companies "receive the same level of regulatory oversight and scrutiny as domestic ...

Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...

Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria (CSU), a condition that causes painful hives that often don't respond to ...

A filing by the Department of Justice has asked Judge Matthew Kacsmaryk, a Trump appointee who opposes abortion, to block the ...

Digital therapeutics (DTx) developer Hinge Health has published a new prospectus for an initial public offering (IPO) in the ...

Financial terms of the new agreement include an upfront payment to secure rights to Alchemab's lead ALS candidate, ATLX-1282, ...

The 'Choose Europe for Science' scheme was revealed by President of the European Commission Ursula Von Der Leyen during a ...

The phase 2 PIVOT-HD trial of Novartis-partnered PTC518 (votoplam) showed that the oral mRNA splicing modifier was able to ...